Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.

Ramón TeiraHelena Diaz-CuervoFilipa AragãoSophie MarguetBelén de la FuenteMaria Jose MuñozNadia AbdulghaniEsteban RiberaPere DomingoElisabeth DeigJoaquim PeraireBernardino RocaMarta MonteroMaria José GalindoAlberto RomeroNuria EspinosaFernando LozanoMaría Dolores MerinoElisa MartínezPaloma GeijoVicente EstradaJosefina GarcíaM Antonia SepúlvedaJuan Berenguer

Published in: PloS one (2021)

In this analysis, time to discontinuation and probability of remaining free of virologic failure were significantly higher in patients on INSTI-based TT compared to DTG- and/or bPI-containing 2DC, with no differences in toxicity.

Keyphrases

end stage renal disease
healthcare
newly diagnosed
ejection fraction
randomized controlled trial
systematic review
palliative care
peritoneal dialysis
oxidative stress
dendritic cells
prognostic factors
stem cells
immune response
patient reported outcomes
cell therapy